Eosinophilic cationic protein (ECP) as a marker of graft versus host disease (GVHD) in pediatric allogeneic bone marrow transplantation.

被引：0
|
作者：
Cole, CH [1 ]
Loh, R [1 ]
机构：
[1] PRINCESS MARGARET HOSP CHILDREN,PERTH,WA,AUSTRALIA
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4398 / 4398
页数：1
相关论文
共 50 条
  • [21] The combination of tacrolimus, methotrexate, and methylprednisone completely prevents acute graft-versus-host disease (GVHD) but not chronic GVHD, in unrelated bone marrow transplantation.
    Ogawa, H
    Soma, T
    Hosen, N
    Tsuboi, A
    Oji, Y
    Tamaki, H
    Kawakami, M
    Ikegame, K
    Murakami, M
    Fujioka, T
    Kim, EH
    Oka, Y
    Sugiyama, H
    BLOOD, 2001, 98 (11) : 386B - 386B
  • [22] Effect of Ly49A transfected lymphocytes on graft versus host disease and graft versus leukemia effect after allogeneic bone marrow transplantation.
    李玉华
    ChinaMedicalAbstracts, 2003, (02) : 137 - 138
  • [23] Chemokine profiling in patients with graft versus host disease (GVHD) following allogeneic blood stem cell transplantation.
    Ziegler, Judy A.
    Lokshin, Anna
    Lentzsch, Suzanne
    Agha, Mounzer
    Arnold, Renate
    Mapara, Markus Y.
    BLOOD, 2006, 108 (11) : 814A - 815A
  • [24] Usefulness of serum soluble interleukin-2 receptor concentration as index of engraftment and acute graft-versus-host disease (GVHD) in allogeneic bone marrow transplantation.
    Ariyama, Y
    Urase, F
    Tubaki, K
    Horiuchi, A
    EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 677 - 677
  • [25] Evaluation of the prophylactic effect of graft-versus-host disease (GVHD) from allogeneic bone marrow transplantation by ursodeoxycholic acid.
    Iwata, N
    Kuroiwa, T
    Kataoka, Y
    Nakata, A
    Seto, Y
    Takemoto, Y
    Kakishita, E
    HEPATOLOGY, 1998, 28 (04) : 443A - 443A
  • [26] INDIRECT ASSOCIATION OF ELEVATED SERUM IGE AND GRAFT-VERSUS-HOST DISEASE (GVHD) IN ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT)
    DONNENBERG, AD
    HEYD, J
    BURNS, WH
    SARAL, R
    SANTOS, GW
    EXPERIMENTAL HEMATOLOGY, 1988, 16 (06) : 517 - 517
  • [27] Impaired thymic negative selection causes chronic graft-versus-host disease after allogeneic bone marrow transplantation.
    Sakoda, Y
    Hashimoto, D
    Takeuchi, K
    Asakura, S
    Akashi, K
    Tanimoto, M
    Harada, M
    Teshima, T
    BLOOD, 2005, 106 (11) : 137A - 137A
  • [28] Acute graft versus host disease: A statistical analysis of risk factor in 36 patients submitted to allogeneic bone marrow transplantation.
    Damiani, D
    BLOOD, 1999, 94 (10) : 366B - 367B
  • [29] Photopheresis as a treatment for chronic graft-vs-host disease after allogeneic bone marrow transplantation.
    DiVenuti, G
    Miller, K
    Sprague, K
    Grodman, H
    Foss, F
    BLOOD, 2002, 100 (11) : 846A - 846A
  • [30] Influence of tumor vaccines on graft versus tumor activity and graft versus host disease in allogeneic bone marrow transplantation
    Mullen, CA
    LEUKEMIA & LYMPHOMA, 2002, 43 (03) : 503 - 510
12345